Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424774 · ClinicalTrials.gov registry record
Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning
A clinical trial, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- 155
- Enrollment target
NCT01424774 is a clinical trial that has completed, run by Bracco Diagnostics. The registered enrollment target is 155 participants.
The verdict
NCT01424774 has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
This study will be performed at clinical sites that have administered CardioGen-82® to patients from January to July 2011. The patients enrolled(i.e., "target date patients") will be all those who were dosed at the end of use of the CardioGen-82® generators on the last day of generator use from the generator that was used immediately prior to the recalled generator (i.e., "target date generators"). These are not patients who received drug eluted from the recalled generator. Of these patients, it is planned that 100 patients will be entered in this trial.
Interventions
- DRUG CardioGen-82
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424774
The ClinicalTrials.gov registry entry for NCT01424774 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CardioGen-82 is the first listed.
NCT01424774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01424774 about?
NCT01424774 is a clinical study titled "Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning". This study will be performed at clinical sites that have administered CardioGen-82® to patients from January to July 2011. The patients enrolled(i.e., "target date patients") will be all those who were dosed at the end of use of the CardioGen-82® generators on the last day of generator use from the ...
What is the current status of trial NCT01424774?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2011-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01424774?
The interventions under investigation include: CardioGen-82 (DRUG).
Who is sponsoring clinical trial NCT01424774?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.